CIK治疗耐药性非霍奇金淋巴瘤疗效观察

The Curative Effect To Observe Cytokine Induced Killer Treatment Tolerance Non-Hodgkin Lymphoma

目的探讨CIK治疗耐药性非霍奇金淋巴瘤的效果。方法对5例经病理确诊为非霍奇金淋巴瘤且存在化疗耐药、多处结外器官侵犯的患者进行CIK治疗并观察治疗前后侵犯部位肿块的变化。结果所有患者通过影像学复查显示肿瘤明显缩小,2例多发侵犯性患者治疗前后显示完全消失。结论CIK细胞治疗耐药性非霍奇金淋巴瘤安全有效,为耐药性非霍奇金淋巴瘤的治疗提供了1种新的有效的免疫治疗手段。应用CIK细胞将是难治性或耐药性非霍奇金淋巴瘤治疗的1个新的重要方向。

Objective To discuss the effect of cytokine induced killer Treatment tolerance non-Hodgkin lymphoma. Methods Collect 5 case final diagnosis non-Hodgkin lymphoma with pathology,and existence drug resistance,many Organs to offend,process cytokine induced killer Treatment and Observing tumour＇s Change of trespass on part in treatment. Results All patiens review with screenage diplay diminution of tumour,2 case multi invasive patien diplay extinction completely with cytokine pretherapy. Conclusion Cytokine induced killer Treatment tolerance non-Hodgkin lymphoma is .safe and efficacious, provid a new and efficacious Immunity therapeutic tool for Treatment tolerance non-Hodgkin lymphoma. Application cytokine induce killer treatment is a new and important direction for treatment refractory or tolerance non - Hodgkin lymphoma.